Koers Fresenius SE & Co. KGaA Other OTC
Aandelen
FSNUY
US35804M1053
Gezondheidszorgvoorzieningen & -diensten
Omzet 2024 * | 22,19 mld. 24,09 mld. | Omzet 2025 * | 23,33 mld. 25,33 mld. | Marktkapitalisatie | 15,5 mld. 16,83 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,41 mld. 1,53 mld. | Nettowinst (verlies) 2025 * | 1,74 mld. 1,89 mld. | EV/omzet 2024 * | 1,26 x |
Nettoschuld 2024 * | 12,44 mld. 13,5 mld. | Nettoschuld 2025 * | 11,7 mld. 12,71 mld. | EV/omzet 2025 * | 1,17 x |
K/w-verhouding 2024 * |
11,1
x | K/w-verhouding 2025 * |
8,81
x | Werknemers | - |
Dividendrendement 2024 * |
3,43% | Dividendrendement 2025 * |
3,78% | Vrij verhandelbaar | 73,04% |
Recentste transcriptie over Fresenius SE & Co. KGaA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 12-04-21 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 01-01-19 |
Michael Moser
CMP | Compliance Officer | - | 18-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 20-05-15 |
Wolfgang Kirsch
CHM | Chairman | 69 | 01-01-20 |
Director/Board Member | 63 | 13-05-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,63% | 85,14 mld. | |
-27,41% | 72,06 mld. | |
+2,75% | 27,07 mld. | |
-9,66% | 17,43 mld. | |
+3,96% | 16,02 mld. | |
+7,75% | 13,87 mld. | |
+72,83% | 13,06 mld. | |
+72,50% | 12,79 mld. | |
+32,39% | 12,36 mld. |